跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
VASCEPA - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
VASCEPA
Authorized
STANDARD
VASCEPA
海倫司國際控股有限公司
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
fe884176680c852f
Company
海倫司國際控股有限公司
Type
Standard
Approval Details
Approval Id
fe884176680c852f
Drug Approval Canada Name
VASCEPA
Product Name
VASCEPA
Status
Marketed
Status Date
2020-02-07
Original Market Date
2020-02-07
Din
02495244
Drug Class
Human
Dosage Form
Capsule
Route Of Administration
Oral
Schedule
Prescription
Ahfs
24:06.92
Atc Original
C10AX OTHER LIPID MODIFYING AGENTS
Atc Name
c 10 ax
Aig Number
0162013001
Company Name
海倫司國際控股有限公司
Company Address
10 Carlson Court, Suite 701, Etobicoke, Ontario, Canada, M9W 6L2
Active Ingredients
ICOSAPENT ETHYL
1 G
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
fe884176680c852f
Type
Standard
Back to Health Canada Approvals